Home > Press > Initiative to Promote Commercial Uptake of Microfluidic Devices: International Microfluidic Consortium driving Standardization Activities for Solutions in Healthcare, Environmental Applications, and Beyond
Abstract:
The industrial and consumer use of microfluidic solutions in components and instruments is hampered by the lack of standardized interconnects. Just as mobile electronics was enabled by standardized interconnects like USB and Bluetooth, general adoption of microfluidics will only be possible with an agreement on standardized interconnects between chips and systems. Clearly, microfluidics is even more diverse than electronics, so one size fits all and different applications will need different classes of interconnect.
The MF-3 Microfluidic Consortium (a group of companies including SonyDADC, Philips, ST-Microelectronics, Biocartis, Dolomite and Micronit) was aware of how this fragmentation was slowing market uptake and decided to act. As a first step it divided the needed interconnect schemes into three groups:
1) Higher temperature/pressure interconnects for research, analytical and process instruments based on reusable chips.
2) Chips holders including microfluidic and electrical and/or optical interconnects for analytical and process instruments based on reusable chips.
3) Interconnects for disposable chips for health care and diagnostics.
At the consortium's recent meeting in Milan a draft proposal for higher temperature/ pressure interconnects was accepted and is planned to be published shortly. Multinational and SME Members of the MF3 consortium have put forward suggestions for addressing a variety of applications for microfluidic interconnects.
The MF3 consortium is now calling for further expressions of user requirements for microfluidic interconnects. The consortium's work seeking to address such key needs in a standardized manner will grow the market for microfluidic enabled solutions. These proposals will be discussed in workshops organized by the Consortium later in this year.
####
About MF3 Microfluidics Consortium
The MF3 Microfluidics Consortium brings together stakeholders from all parts of the value chain with a shared interest in growing the market for microfluidics enabled solutions to 'Grand Challenges' in healthcare, environment and beyond. One of its activities is to promote standards, platform solutions and interoperability. This collaborative approach will ultimately drive down costs to end users and drive up volumes. It helps its members to engage with key stakeholders such as regulators, patent offices and procurement agencies as well as stimulating commercial opportunities. The consortium was launched in June 2008 and is open for further members world-wide.
For more information, please click here
Contacts:
Membership:
Peter Hewkin
United Kingdom
Phone: +44 7951721110
E-Mail:
www.cfbi.com
Standardization programme:
Henne van Heeren
The Netherlands
Phone: +31 654954621
E-Mail:
Copyright © MF3 Microfluidics Consortium
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Industrial
Boron nitride nanotube fibers get real: Rice lab creates first heat-tolerant, stable fibers from wet-spinning process June 24th, 2022
Nanotubes: a promising solution for advanced rubber cables with 60% less conductive filler June 1st, 2022
Protective equipment with graphene nanotubes meets the strictest ESD safety standards March 25th, 2022
OCSiAl receives the green light for Luxembourg graphene nanotube facility project to power the next generation of electric vehicles in Europe March 4th, 2022
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||